The Enterprise Value as of September 2024 (TTM) for Gamida Cell Ltd. (GMDA) is 57.65M

According to Gamida Cell Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 57.65M. This represents a change of -57.30% compared to the average of 135.00M of the last 4 quarters.

Gamida Cell Ltd. (GMDA) Historical Enterprise Value (quarterly & annually)

How has GMDA Enterprise Value performed in the past?

The mean historical Enterprise Value of Gamida Cell Ltd. over the last ten years is 123.35M. The current 57.65M Enterprise Value has changed 4.57% with respect to the historical average. Over the past ten years (40 quarters), GMDA's Enterprise Value was at its highest in in the March 2021 quarter at 374.23M. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Gamida Cell Ltd. (GMDA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gamida Cell Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gamida Cell Ltd. (GMDA) Average Enterprise Value

How has GMDA Enterprise Value performed in the past?

The current Enterprise Value of Gamida Cell Ltd. (GMDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Gamida Cell Ltd. (GMDA) Enterprise Value vs. Peers

How is GMDA’s Enterprise Value compared to its peers?

Gamida Cell Ltd.’s Enterprise Value is less than BioLineRx Ltd. (77.24M), less than Ardelyx, Inc. (1.38B), less than Lexicon Pharmaceuticals, Inc. (652.06M), less than Seres Therapeutics, Inc. (286.75M), less than ImmunityBio, Inc. (3.22B), less than Protalix BioTherapeutics, Inc. (0), less than Iovance Biotherapeutics, Inc. (76.30M), less than ImmunoGen, Inc. (2.89B), less than X4 Pharmaceuticals, Inc. (8.19B), greater than Inozyme Pharma, Inc. (40.79M), less than Terns Pharmaceuticals, Inc. (343.89M), less than Day One Biopharmaceuticals, Inc. (458.36M), less than HOOKIPA Pharma Inc. (1.01B), less than null (87.25M),

Build a custom stock screener for Gamida Cell Ltd. (GMDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gamida Cell Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gamida Cell Ltd. (GMDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gamida Cell Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.